SCHEMBL24310189

SCHEMBL24310189

c1ccc(Oc2cc(-c3ccccc3)nc(NSN3CCCC3)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ MAPT P10636 4/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GPR39 O43194 1/20 0.43
▸ CYP1A2 P05177 3/20 0.42
▸ CYP2C9 P11712 3/20 0.42
▸ CYP2C19 P33261 3/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ADORA1 P30542 4/20 0.38
▸ ADORA2A P29274 2/20 0.38
▸ HPGD P15428 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310188 0.80 MAPK1 (0.50) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL24309752 0.78 MAPK1 (0.57) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL24309688 0.74 MAPK1 (0.46) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL24310176 0.73 MAPK1 (0.51) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL24309653 0.73 MAPK1 (0.51) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812998 0.72 TDP1 (0.54) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812905 0.72 MAPK1 (0.50) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26806813 0.72 MAPT (0.61) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812929 0.72 MAPK1 (0.52) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL24310546 0.71 MAPK1 (0.49) MAPK1TDP1MAPTALDH1A1GPR39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback